These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10595958

  • 1. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
    Chen HH, Schirger JA, Chau WL, Jougasaki M, Lisy O, Redfield MM, Barclay PT, Burnett JC.
    Circulation; 1999 Dec 14; 100(24):2443-8. PubMed ID: 10595958
    [Abstract] [Full Text] [Related]

  • 2. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL, Stevens TL, Cataliotti A, Schirger JA, Borgeson DD, Redfield MM, Luchner A, Burnett JC.
    Kidney Int; 2005 May 14; 67(5):1723-30. PubMed ID: 15840018
    [Abstract] [Full Text] [Related]

  • 3. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Chen HH, Lainchbury JG, Matsuda Y, Harty GJ, Burnett JC.
    Hypertension; 2001 Aug 14; 38(2):187-91. PubMed ID: 11509474
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
    Margulies KB, Perrella MA, McKinley LJ, Burnett JC.
    J Clin Invest; 1991 Nov 14; 88(5):1636-42. PubMed ID: 1658047
    [Abstract] [Full Text] [Related]

  • 5. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB, Barclay PL, Burnett JC.
    Circulation; 1995 Apr 01; 91(7):2036-42. PubMed ID: 7895362
    [Abstract] [Full Text] [Related]

  • 6. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
    Chen HH, Lainchbury JG, Harty GJ, Burnett JC.
    Circulation; 2002 Feb 26; 105(8):999-1003. PubMed ID: 11864932
    [Abstract] [Full Text] [Related]

  • 7. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
    Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, Burnett JC.
    Circulation; 1990 Jul 26; 82(1):196-201. PubMed ID: 2142023
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of renal neutral endopeptidase in severe heart failure.
    Knecht M, Pagel I, Langenickel T, Philipp S, Scheuermann-Freestone M, Willnow T, Bruemmer D, Graf K, Dietz R, Willenbrock R.
    Life Sci; 2002 Oct 25; 71(23):2701-12. PubMed ID: 12383878
    [Abstract] [Full Text] [Related]

  • 9. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T, Wada A, Ohnishi M, Tsutamoto T, Fujii M, Matsumoto T, Takayama T, Wang X, Kurokawa K, Kinoshita M.
    Clin Sci (Lond); 2002 Aug 25; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [Abstract] [Full Text] [Related]

  • 10. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P, Sisson D, Thomas W, Goetze L.
    J Pharmacol Exp Ther; 2000 Jun 25; 293(3):989-95. PubMed ID: 10869402
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A, Tsutamoto T, Matsuda Y, Kinoshita M.
    Circulation; 1994 May 25; 89(5):2232-40. PubMed ID: 7910118
    [Abstract] [Full Text] [Related]

  • 14. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.
    Fukai D, Wada A, Tsutamoto T, Kinoshita M.
    Jpn Circ J; 1998 Aug 25; 62(8):604-10. PubMed ID: 9741739
    [Abstract] [Full Text] [Related]

  • 15. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
    Tikkanen I, Helin K, Tikkanen T, Sybertz EJ, Vemulapalli S, Sariola H, Näveri H, Fyhrquist F.
    J Pharmacol Exp Ther; 1990 Aug 25; 254(2):641-5. PubMed ID: 2143536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH, Cataliotti A, Schirger JA, Martin FL, Burnett JC.
    Am J Physiol Regul Integr Comp Physiol; 2005 May 25; 288(5):R1093-7. PubMed ID: 15627648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.